Dong Xi

InstitutionHuaZhong University of Science and Technology
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 5 Covid-19 publications, with a maximum of 2 publications in August 2020
    All Publications
    Bar chart showing 53 publications over 18 distinct years, with a maximum of 6 publications in 2008
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Han MW, Wang M, Xu MY, Qi WP, Wang P, Xi D. Clinical features and potential mechanism of coronavirus disease 2019-associated liver injury. World J Clin Cases. 2021 Jan 26; 9(3):528-539. PMID: 33553391.
      Citations: 2     
    2. Wang M, Yan W, Qi W, Wu D, Zhu L, Li W, Wang X, Ma K, Ni M, Xu D, Wang H, Chen G, Yu H, Ding H, Xing M, Han M, Luo X, Chen T, Guo W, Xi D, Ning Q. Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China. Hepatol Int. 2020 Sep; 14(5):723-732. PMID: 33026573.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    3. Kunz CU, J├Ârgens S, Bretz F, Stallard N, Van Lancker K, Xi D, Zohar S, Gerlinger C, Friede T. Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue? Stat Biopharm Res. 2020 Aug 19; 12(4):461-477. PMID: 34191979.
      Citations: 2     
    4. Akacha M, Branson J, Bretz F, Dharan B, Gallo P, Gathmann I, Hemmings R, Jones J, Xi D, Zuber E. Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials. Stat Biopharm Res. 2020 Aug 17; 12(4):419-426. PMID: 34191974.
      Citations: 1     
    5. Zhang Y, Wang X, Li X, Xi D, Mao R, Wu X, Cheng S, Sun X, Yi C, Ling Z, Ma L, Ning Q, Fang Y, Sun B, Wu D. Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients. Cell Mol Immunol. 2020 08; 17(8):878-880. PMID: 32587367.
      Citations: 19     Fields:    Translation:HumansCellsPHPublic Health
    6. Yu H, Liu Y, Wang H, Wan X, Huang J, Yan W, Xi D, Luo X, Shen G, Ning Q. Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression. Front Immunol. 2018; 9:2935. PMID: 30619295.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    7. Yu H, Liu Y, Huang J, Wang H, Yan W, Xi D, Shen G, Luo X, Ning Q. IL-33 protects murine viral fulminant hepatitis by targeting coagulation hallmark protein FGL2/fibroleukin expression. Mol Immunol. 2017 07; 87:171-179. PMID: 28494352.
      Citations: 3     Fields:    Translation:AnimalsCells
    8. Wu D, Wang H, Yan W, Chen T, Wang M, Han M, Wu Z, Wang X, Ai G, Xi D, Shen G, Luo X, Ning Q. A disparate subset of double-negative T cells contributes to the outcome of murine fulminant viral hepatitis via effector molecule fibrinogen-like protein 2. Immunol Res. 2016 Apr; 64(2):518-30. PMID: 26482053.
      Citations: 4     Fields:    Translation:AnimalsCells
    9. Wang X, Yan W, Lu Y, Chen T, Sun Y, Qin X, Zhang J, Han M, Guo W, Wang H, Wu D, Xi D, Luo X, Ning Q. CD4-CD8-T cells contribute to the persistence of viral hepatitis by striking a delicate balance in immune modulation. Cell Immunol. 2012 Nov; 280(1):76-84. PMID: 23261832.
      Citations: 1     Fields:    Translation:AnimalsCells
    10. Zhou YY, Zou Y, Chen T, Wang HW, Han MF, Pi B, Yan WM, Xi D, Huang JQ, Luo XP, Ning Q. [KCTD9, a novel potassium channel related gene, was highly expressed in hepatic NK cells and T cells of fulminant hepatitis mice induced by MHV-3]. Zhonghua Gan Zang Bing Za Zhi. 2011 Nov; 19(11):833-7. PMID: 22433305.
      Citations: 2     Fields:    Translation:AnimalsCells
    11. Gao S, Wang M, Ye H, Guo J, Xi D, Wang Z, Zhu C, Yan W, Luo X, Ning Q. Dual interference with novel genes mfgl2 and mTNFR1 ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Hum Gene Ther. 2010 Aug; 21(8):969-77. PMID: 20218879.
      Citations: 11     Fields:    Translation:AnimalsCells
    12. Gao S, Wang M, Guo JW, Xi D, Luo XP, Ning Q. Construction of mTNFR1shRNA plasmid and its biological effects on MHV-3 induced fulminant hepatitis in BALB/cJ mice. Virol Sin. 2010 Feb; 25(1):52-8. PMID: 20960284.
      Citations:    Fields:    Translation:AnimalsCells
    13. Wang H, Han M, Yao H, Wang Z, Xi D, Yan W, Hou J, Luo X, Ning Q. Construction of plasmids expressing Sars-CoV encoding proteins and their effects on transcription of hfgl2 prothrombinase. J Huazhong Univ Sci Technolog Med Sci. 2009 Jun; 29(3):318-23. PMID: 19513614.
      Citations:    Fields:    Translation:HumansAnimalsCells
    14. Han M, Yan W, Huang Y, Yao H, Wang Z, Xi D, Li W, Zhou Y, Hou J, Luo X, Ning Q. The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha. J Biochem. 2008 Jul; 144(1):51-62. PMID: 18390877.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    15. Zhu C, Sun Y, Luo X, Yan W, Xi D, Ning Q. Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Hum Gene Ther. 2006 Jun; 17(6):589-600. PMID: 16776568.
      Citations: 23     Fields:    Translation:AnimalsCells
    16. Zhu CL, Yan WM, Zhu F, Zhu YF, Xi D, Tian DY, Levy G, Luo XP, Ning Q. Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B. World J Gastroenterol. 2005 Nov 28; 11(44):6936-40. PMID: 16437596.
      Citations: 19     Fields:    Translation:HumansAnimalsCells
    17. Wei P, Fan K, Chen H, Ma L, Huang C, Tan L, Xi D, Li C, Liu Y, Cao A, Lai L. The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase. Biochem Biophys Res Commun. 2006 Jan 20; 339(3):865-72. PMID: 16329994.
      Citations: 34     Fields:    Translation:Cells